Amgen (AMGN) Misses Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street rises on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Amgen (AMGN) PT Raised to $205 at Bernstein Following 4Q
February 2, 2018 8:06 AM ESTBernstein raised its price target on Amgen (NASDAQ: AMGN) to $205.00 (from $189.00) while maintaining a Market Perform rating following the company's 4Q earnings report. Amgen missed a bit on top line with a bit more of a material miss on EPS ($5,602, -0.7%; $2.89, -14c). The... More
Amgen (AMGN) PT Lowered to $196 at Morgan Stanley
February 2, 2018 6:56 AM ESTMorgan Stanley lowered its price target on Amgen (NASDAQ: AMGN) to $196.00 (from $204.00) while maintaining a Overweight rating.
... MoreAmgen (AMGN) PT Raised to $224 at Oppenheimer
February 2, 2018 6:54 AM ESTOppenheimer raised its price target on Amgen (NASDAQ: AMGN) to $224.00 (from $205.00) while maintaining an Outperform rating.
Analyst Leah Rush Cann commented, "Amgen reported GAAP earnings per share, before a one-time tax-reform charge, of $2.70, which is 9.2% lower than our estimate of $2.97. Earnings were... More
